![Citius Pharma on X: "Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok Phase 3 Trial as Planned Read the full news release here: https://t.co/ZAE0LHWSyP $CTXR # Citius Pharma on X: "Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok Phase 3 Trial as Planned Read the full news release here: https://t.co/ZAE0LHWSyP $CTXR #](https://pbs.twimg.com/media/E5Nu8feVgAEPSpZ.jpg)
Citius Pharma on X: "Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok Phase 3 Trial as Planned Read the full news release here: https://t.co/ZAE0LHWSyP $CTXR #
![04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT 04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT](https://image.slidesharecdn.com/04takakihatsui-200415060122/85/04-new-opportunities-in-photon-science-with-highspeed-xray-imaging-detector-citius-and-associated-data-challenge-2-320.jpg?cb=1669001608)
04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT
![04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT 04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT](https://image.slidesharecdn.com/04takakihatsui-200415060122/85/04-new-opportunities-in-photon-science-with-highspeed-xray-imaging-detector-citius-and-associated-data-challenge-1-320.jpg?cb=1669001608)
04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT
![Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS") | CTXR Stock News Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS") | CTXR Stock News](https://static.stocktitan.net/company-logo/ctxr.png)
Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS") | CTXR Stock News
![04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT 04 New opportunities in photon science with high-speed X-ray imaging detector CITIUS, and associated data challenge | PPT](https://image.slidesharecdn.com/04takakihatsui-200415060122/85/04-new-opportunities-in-photon-science-with-highspeed-xray-imaging-detector-citius-and-associated-data-challenge-27-320.jpg?cb=1669001608)